Smartablate
Payments companies reported to CMS as associated with Smartablate. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Smartablate, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Smartablate
These are the largest totals companies reported as associated with Smartablate. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Hiroshi Nakagawa | Oklahoma City, OK | $153.60 | |
| Robert Kim | Jacksonville, FL | Clinical Cardiac Electrophysiology | $150.00 |
| Shervin Sadrpour | Encino, CA | Clinical Cardiac Electrophysiology | $146.55 |
| Adam Price | Live Oak, TX | Clinical Cardiac Electrophysiology | $141.81 |
| Gregg Gerasimon | San Antonio, TX | Clinical Cardiac Electrophysiology | $141.81 |
| Christopher Ruisi | Jacksonville, FL | Clinical Cardiac Electrophysiology | $139.61 |
| Venkata Sagi | Jacksonville, FL | Clinical Cardiac Electrophysiology | $139.61 |
| Christopher Madias | Boston, MA | Clinical Cardiac Electrophysiology | $106.78 |
| Guy Rozen | Melrose, MA | Cardiovascular Disease | $59.05 |
| Matthew Cain | Saint Helena, CA | Clinical Cardiac Electrophysiology | $53.35 |
Prescribed Smartablate?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.